iShares MSCI New Zealand ETF (ENZL) is an exchange-traded fund that seeks to track the investment results of the MSCI New Zealand IMI 25/50 Index, composed of equity securities of large-, mid- and small-capitalization New Zealand companies. The fund provides investors with targeted exposure to the New Zealand equity market through a portfolio of stocks selected and weighted based on the benchmark index's methodology; it employs a representative sampling strategy to replicate the index's performance while minimizing tracking error. ENZL offers diversified holdings across sectors including materials, industrials, health care, and consumer staples, with key constituents such as Fisher & Paykel Healthcare Corporation Ltd., Auckland International Airport Ltd., and Spark New Zealand Ltd.
Operated by BlackRock Fund Advisors, a division of BlackRock, Inc., the fund was launched in September 2010 and is domiciled in the United States with its principal place of business in San Francisco, California. It trades on the NYSE Arca exchange under the ticker ENZL and is available to institutional and retail investors seeking geographic diversification into the Australasian region. The fund's geographic focus remains exclusively on New Zealand-based issuers, with no significant operations or subsidiaries outside this scope.
In recent developments, ENZL benefited from BlackRock's broader strategic enhancements in 2024-2025, including the integration of advanced AI-driven analytics across its iShares ETF platform to improve portfolio optimization and risk management tools for investors. The fund saw increased assets under management amid heightened global interest in emerging Pacific markets following New Zealand's economic rebound post-2023 slowdown, driven by commodity exports and tourism recovery. No major structural changes, such as index reconstitutions, mergers, or product rebrands, were reported for ENZL in the last two years, maintaining its steady focus on the MSCI benchmark amid stable fund flows.